Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary

Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial.

JCO clinical cancer informatics·2025

Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.

Leukemia & lymphoma·2025

PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma.

American journal of hematology·2025

Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.

The Lancet. Haematology·2024

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis.

Blood advances·2024

Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.

Blood advances·2024

Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

Clinical advances in hematology & oncology : H&O·2026

Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.

Clinical advances in hematology & oncology : H&O·2026

Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

Clinical advances in hematology & oncology : H&O·2026

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026

Memory B cell response to SARS-CoV-2 vaccination in people with heart and lung transplantation: Identification of associated clinical factors.

iScience·2026

Immune dysregulatory disorders: perspective from solving a diagnostic odyssey.

Current opinion in pediatrics·2026

Vitamin D Receptor BsmI Polymorphism and Inflammatory Features in Juvenile Idiopathic Arthritis.

Immunological investigations·2026

Molecular biomarker profiling in noninfectious uveitis: a chronological review of discovery.

Current opinion in ophthalmology·2026

[Immunocyte energy metabolism imbalance and precision treatment in vitiligo: Mechanistic insights and advances in targeted intervention].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2026

Immunometabolic interactions in gynecologic cancers: Mechanisms, biomarkers, and therapeutic implications.

The Journal of international medical research·2026

Related Experiment Videos

Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary

Related Concept Videos

Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial.

Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.

PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma.

Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis.

Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.

Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and future.

Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Memory B cell response to SARS-CoV-2 vaccination in people with heart and lung transplantation: Identification of associated clinical factors.

Immune dysregulatory disorders: perspective from solving a diagnostic odyssey.

Vitamin D Receptor BsmI Polymorphism and Inflammatory Features in Juvenile Idiopathic Arthritis.

Molecular biomarker profiling in noninfectious uveitis: a chronological review of discovery.

[Immunocyte energy metabolism imbalance and precision treatment in vitiligo: Mechanistic insights and advances in targeted intervention].

Immunometabolic interactions in gynecologic cancers: Mechanisms, biomarkers, and therapeutic implications.

Related Experiment Videos

Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary

Related Concept Videos

Related Articles